Author Topic: Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results  (Read 91 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results

The three-year trial results revealed that a once-a-week tirzepatide injection for adults who are prediabetic, obese, or overweight reduced their risk of progressing to type 2 diabetes by 94%.
Source: Tirzepatide Cuts Diabetes Risk By 94% In Prediabetic, Obese Individuals: Trial Results
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)


 


Powered by EzPortal